Eiken Chemical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eiken Chemical Co., Ltd. with three other
companies in this sector in Japan:
Nippon Chemiphar Co., Ltd.
sales of 35.69 billion Japanese Yen [US$321.20 million]
of which 97%
was Pharmaceutical Business),
(29.59 billion Japanese Yen [US$266.30 million]
of which 82%
was Pharmaceutical Products), and
Fuso Pharmaceutical Industries Ltd
(46.78 billion Japanese Yen [US$421.04 million]
of which 100%
was Pharmaceutical Business).
Eiken Chemical Co., Ltd. reported sales of ¥33.27 billion (US$299.47 million)
March of 2017.
increase of 3.5%
versus 2016, when the company's sales were ¥32.16 billion.
Sales at Eiken Chemical Co., Ltd. have increased during each of the previous five years
(and since 2012, sales have increased a total of 20%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
15.6% in 2017, from
¥4.24 billion to ¥4.90 billion.
Eiken Chemical Co., Ltd. also saw significant increases in sales in
Microbes Test Agent (up 10.0% to ¥5.06 billion)
Urine Test Agent (up 6.3% to ¥2.45 billion)
Not all segments of Eiken Chemical Co., Ltd. experienced an increase in sales in 2017:
sales of Biological Test Agent fell 5.0% to ¥611.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Eiken Chemical Co., Ltd. also experienced decreases in sales in
Immunoserology Test Agent (down 0.5% to ¥18.05 billion)
Instruments and Food and Environment Related (down 1.6% to ¥2.20 billion)